AusPAR: Neratinib (as maleate)

Australian Public Assessment Report

AusPAR

AusPAR: Neratinib (as maleate) [PDF, 685.98 KB]

AusPAR: Neratinib (as maleate) [Word, 915.08 KB]

AusPAR Attachment 1: Product Information for Neratinib (as maleate) [PDF, 273.47 KB]

AusPAR Attachment 1: Product Information for Neratinib (as maleate) [Word, 443.88 KB]

Device/Product Name

Nerlynx

Active ingredients

Neratinib (as maleate)

AusPAR Date

12 May 2020

Published

15 May 2020

Submission Number

PM-2018-00968-1-4

Submission Type

New chemical entity

Decision

Approved